LSMedical OÜ – Strategic-Technological Analysis
13 pages · PDF · 18 January 2026 · Licensed single-user copy, watermarked to the buyer
€299 excl. VAT — EU VAT calculated at checkout (VAT ID accepted for reverse charge); invoice issued after payment
One click to Stripe — guest checkout, no account. Your download appears on the confirmation page and arrives by e-mail right after payment (link valid 72 hours, up to 5 downloads).
About this report
LSMedical OÜ, founded in 2020 in Tallinn, Estonia, is a deep-tech startup specialising in high-performance magnets and magnetic nanomaterials for industrial and medical applications . Its core value proposition is the development of rare-earth-free magnet technology (notably iron-nitride, Fe₁₆N₂-based magnets), enabling strong magnetic performance without dependence on critical Chinese supplies.
This innovation directly addresses European strategic autonomy objectives in critical materials: by replacing neodymium-based magnets (where over 90% of supply comes from China) with iron-nitride alternatives, LSMedical’s approach enhances EU supply-chain resilience and competitiveness .
Key questions this report answers
- What is LSMedical's core rare-earth-free magnet technology (iron-nitride, Fe16N2-based) and magnetic nanomaterials capability?
- How mature is the technology, and how does it reduce dependence on Chinese-dominated neodymium supply?
- How do its dual-use industrial and medical applications and partnerships support European critical-materials autonomy?
- What capability gaps and strategic indicators define LSMedical's contribution to supply-chain resilience?
Inside this report
- Executive Summary
- 1. Corporate Identity & Legal Structure
- 2. Strategic Business Profile
- 3. Technology Portfolio Mapping
- 4. Technology Readiness Assessment
- 5. European Strategic Program Participation
- 6. Academic & Research Origins
- 7. Dual-Use Applications & European Market Strategy
- 8. Strategic Partnerships & Industrial Alliances
- 9. European Market Focus & Operational Domains
- 10. Intellectual Property & European Innovation Assets
- 11. Leadership & European Technical Expertise
- 12. Capability and Gap Analysis
- 13. Strategic Indicators & European Innovation Metrics
Who it's for
Investors screening LSMedical OÜ, competitors and partners assessing their position, and analysts who need a sourced, structured account of the entity and its technology.
Related reports
Methodology, format & delivery
DFM reports are built from primary and official sources — TED procurement notices, CORDIS and the EU Funding & Tenders Portal, EIB operations, the NATO Innovation Fund portfolio, SIPRI data, official budget documents and company disclosures — read together with the underlying legal texts. Sources are cited in the document; it reflects them as of its publication date (18 January 2026). You receive a 13-page PDF, watermarked to you on every page, delivered on the confirmation page and by e-mail immediately after checkout (personal link valid 72 hours, up to 5 downloads). Guest checkout, single-user licence — Terms of Sale.
Related on DFM
More Tactical reports · Nanomaterials · Free summary of this report · All reports
Prefer unlimited access?
Prefer unlimited access? Every report like this is included in the DFM Analysis subscription. See plans →